Human genetic material was illegally exported
Print Edition
SIX companies and an institution, including Shanghai’s Huashan Hospital and the China branch of global biopharmaceutical giant AstraZeneca, which is registered in Shanghai, have been punished by China’s Ministry of Science and Technology for violations of human genetic resources management regulations.
The Huashan Hospital, affiliated to Fudan University, and biotech firm BGI in Shenzhen, were found to have conducted international cooperation and research on Chinese human genetic resources with the University of Oxford without permission.
The hospital was ordered to stop the research immediately and destroy all genetic resources materials and relevant research data which has not been passed overseas.
AstraZeneca (China) was given a warning. The human genetic resources materials illegally used was confiscated and destroyed.
Amoy Dx, a biological medicine company based in Xiamen, Q2 Solutions, a global clinical trials laboratory services organization based in Beijing, and BGI were also punished by the ministry.
The Suzhou outlet of pharmaceutical company AppTec Group was found to have exported 5,165 human genetic resources, or human serum, overseas as canine plasma illegally.
It was given a warning, had the human genetic resources materials in the project confiscated and destroyed, and its international cooperation and overseas activities regarding China’s human genetic resources was suspended.
It will not be able to resume this work until its rectification passes inspection.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
